1.
Eksp Klin Farmakol
; 63(2): 51-3, 2000.
Artículo
en Ruso
| MEDLINE
| ID: mdl-10834095
RESUMEN
The effect of phencarol, ranitidine, propranolol, atropine, and diethylstilbestrol (known as modulators of the tamoxifen-binding sites in plasma membranes) on the 3H-tamoxifen binding to the plasma membrane fraction of white rat uterine cells was studied by determining the amounts of estradiol and H1- and H2-receptors. The interaction of tamoxifen with various receptors of uterine cells may be significant for evaluation of the tumor activity of this compound.